Barclays Remains a Sell on Waters (WAT)
TipRanksApr 10 02:48 ET
Analysts Offer Insights on Healthcare Companies: Waters (WAT) and UnitedHealth (UNH)
TipRanksApr 5 00:20 ET
Waters Analyst Ratings
BenzingaApr 4 13:04 ET
Waters Analyst Ratings
BenzingaFeb 12 12:29 ET
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Waters (WAT) and Biohaven Ltd. (BHVN)
TipRanksFeb 12 08:32 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Baxter International (BAX) and Waters (WAT)
TipRanksFeb 11 20:20 ET
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Waters (WAT) and Bristol-Myers Squibb (BMY)
TipRanksFeb 7 08:30 ET
Waters Corporation: Cautious Hold Amidst China Headwinds and Mixed Outlook
TipRanksFeb 7 08:26 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Qiagen (QGEN) and Waters (WAT)
TipRanksFeb 6 21:30 ET
BofA Securities Raises Price Target on Waters to $328 From $300, Maintains Neutral Rating
MT NewswiresJan 29 10:35 ET
Waters Analyst Ratings
BenzingaJan 25 09:58 ET
Waters Analyst Ratings
BenzingaDec 13, 2023 04:55 ET
BofA Securities Adjusts Price Target on Waters to $300 From $265, Maintains Neutral Rating
MT NewswiresDec 12, 2023 10:47 ET
Waters Analyst Ratings
BenzingaDec 11, 2023 07:14 ET
Waters Corporation Downgraded at Barclays Citing Industry Headwinds
Seeking AlphaNov 13, 2023 11:15 ET
Barclays Downgrades Waters to Underweight, Lowers Price Target to $230
BenzingaNov 13, 2023 08:20 ET
Waters Analyst Ratings
BenzingaNov 13, 2023 08:19 ET
JP Morgan Maintains Neutral on Waters, Lowers Price Target to $250
BenzingaNov 8, 2023 15:50 ET
Waters Analyst Ratings
BenzingaNov 8, 2023 15:49 ET
Deutsche Bank Adjusts Waters Price Target to $260 From $295, Maintains Hold Rating
MT NewswiresNov 8, 2023 10:57 ET
No Data
No Data